Growth N. V. Biotech is 10% Owner at Radius Health, Inc. (RDUS). They have made 32 open-market trades across 3 companies since 2014, most recently 2025-03-19.
CIK 0001259869
31 open-market purchases totalling $86.5M since 2014, against 1 sale. Across 31 scored buys the stock is up 5.0% at ninety days, and 2.0 points ahead of the S&P over the same stretch.
31 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 26% | 35% | 52% |
| Avg Move | -8.4% | -3.5% | +5.0% |
| Alpha | -7.4% | -5.0% | +2.0% |
| Scored | 31 | 31 | 31 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BDTX | SELL | 2025-03-19 | 2025-03-20 | $2.06 | $15.2M | -17.2% | -17.2% | +29.4% |
| BDTX | BUY | 2023-10-17 | 2023-10-19 | $2.34 | $936K | -11.7% | +5.6% | +28.2% |
| BDTX | BUY | 2023-06-27 | 2023-06-29 | $5.49 | $9.6M | -7.3% | -29.9% | -45.9% |
| BDTX | BUY | 2022-10-31 | 2022-11-02 | $2.25 | $449K | +10.2% | -12.4% | +33.3% |
| EPIX | BUY | 2022-10-26 | 2022-10-28 | $4.11 | $8.2M | -4.1% | +1.6% | -16.3% |
| EPIX | BUY | 2022-07-14 | 2022-07-18 | $2.93 | $3.5M | -8.8% | -7.9% | -38.1% |
| BDTX | BUY | 2022-04-27 | 2022-04-29 | $2.59 | $1.7M | -23.0% | -30.5% | +44.0% |
| BDTX | BUY | 2022-04-18 | 2022-04-20 | $3.26 | $1.5M | -24.4% | -45.2% | +5.4% |
| BDTX | BUY | 2022-04-12 | 2022-04-14 | $3.51 | $1.2M | -21.6% | -46.4% | -9.5% |
| EPIX | BUY | 2021-08-18 | 2021-08-20 | $8.88 | $2.2M | +16.0% | -2.3% | +55.7% |
| RDUS | BUY | 2019-11-06 | 2019-11-08 | $23.00 | $2.3M | -4.6% | -9.9% | -22.1% |
| RDUS | BUY | 2018-12-20 | 2018-12-21 | $14.48 | $869K | +24.9% | +25.7% | +45.8% |
| RDUS | BUY | 2018-12-14 | 2018-12-17 | $15.64 | $938K | -5.1% | +5.0% | +20.3% |
| RDUS | BUY | 2018-06-11 | 2018-06-13 | $27.36 | $1.4M | -3.6% | -4.9% | -38.9% |
| RDUS | BUY | 2018-04-05 | 2018-04-09 | $36.58 | $1.8M | -7.0% | -11.8% | -20.0% |
| RDUS | BUY | 2017-11-14 | 2017-11-16 | $26.25 | $1.3M | +1.0% | +4.4% | +38.9% |
| RDUS | BUY | 2017-11-03 | 2017-11-07 | $29.15 | $1.5M | -4.3% | -7.4% | +19.9% |
| RDUS | BUY | 2017-10-25 | 2017-10-26 | $32.85 | $1.6M | -6.2% | -9.8% | +27.4% |
| RDUS | BUY | 2017-09-13 | 2017-09-15 | $33.45 | $5.0M | +11.8% | +5.9% | -15.3% |
| RDUS | BUY | 2017-05-30 | 2017-05-31 | $34.21 | $1.4M | +12.1% | +30.3% | +8.3% |
| RDUS | BUY | 2017-05-18 | 2017-05-22 | $34.41 | $3.4M | -5.5% | +19.1% | -3.5% |
| RDUS | BUY | 2017-05-16 | 2017-05-18 | $33.44 | $1.2M | -1.1% | +20.6% | +4.1% |
| RDUS | BUY | 2017-05-09 | 2017-05-11 | $35.93 | $1.8M | +8.3% | +13.4% | +1.9% |
| RDUS | BUY | 2017-05-01 | 2017-05-02 | $35.39 | $5.3M | -1.0% | -2.2% | +22.7% |
| RDUS | BUY | 2017-03-21 | 2017-03-22 | $35.83 | $1.8M | +2.5% | +2.6% | +14.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.